AllPeptides.eu - Advanced Peptide Research
    Research-use-only hub
    2 variants

    Educational protocol hub

    Melanotan II: protocol variants and reconstitution resources

    Educational hub for Melanotan II, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.

    What this hub covers

    This page groups the available Melanotan II protocol variants so readers can choose the exact vial-size guide without mixing formats.

    Reconstitution workflow

    Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.

    Research-only context

    All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.

    Available protocol variants

    Choose the exact guide you want to view.

    Melanotan II

    5mg

    Melanotan II is a synthetic cyclic heptapeptide analog of α-MSH, studied as a melanogenesis stimulant (tanning without UV) via MC1R activation. 5mg vial — reconstitute with 2.5 mL bacteriostatic water for 2 mg/mL (each 1 unit ≈ 20 mcg).

    View protocol

    Melanotan II

    10mg

    Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for causing erectile activity as a side effect. Early human clinical trials identified effective daily doses in the 1–2 mg range for tanning, with conservative protocols starting lower to minimize side effects like nausea and flushing. This protocol presents a once-daily subcutaneous titration approach.

    View protocol

    Related research resources

    Internal links that help readers and search engines understand this peptide topic cluster.

    References

    1. Dorr RT et al. (1996) — Phase I — Clinical study of melanotan-II: dosing and safety assessment
      View Source
    2. International Peptide Society — Melanotan II monograph: dosing & titration protocols
      View Source
    3. DermNet NZ — Dermatology clinical guidance: adverse effects
      View Source
    4. Nelson ME et al. (2012) — Case report: MT-II toxicity and rhabdomyolysis
      View Source
    5. RxList — Melanotan-II — Pharmacology and clinical effects
      View Source

    Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu